(Q42706199)

English

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

scientific article published on 27 March 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

phase III clinical trial

0 references

0 references

1 reference

ChEBI release 2020-05-28

0 references

author name string

David Michelson

1

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Ellen Snyder

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Erin Paradis

3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Mary Chengan-Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Duane B Snavely

5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Jill Hutzelmann

6

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

James K Walsh

7

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Andrew D Krystal

8

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Ruth M Benca

9

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Martin Cohn

10

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Christopher Lines

11

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Thomas Roth

12

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

W Joseph Herring

13

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

publication date

27 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Lancet Neurology

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

461-471

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Chronic insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter stu

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Insomnia pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The orexin system: roles in sleep/wake regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Orexin receptors as therapeutic drug targets

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery of the dual orexin receptor antagonist [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Benzodiazepine Withdrawal Symptom Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of the Insomnia Severity Index as an outcome measure for insomnia research

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Etrank: a ranking procedure for handling missing data in clinical trials: application to venlafaxine extended-release depression clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypocretin (orexin) deficiency in human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970053-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(14)70053-5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42706199&oldid=2207680441"